Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study
Trial details
- Registry ID
- NCT05629390
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Placebo
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA StudyNCT05629390 | LianBio LLC | Phase 3 | Completed | 2023-09-15Actual |
| PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's DiseaseNCT01155362 | Celularity Incorporated | Phase 2 | Completed | 2012-02Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |